Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors. Its structural features enable selective binding to enzyme targets, making it valuable in the production of active pharmaceutical ingredients for oncology and inflammatory disease treatments. The stereochemistry at the pyrrolidinol center enhances biological activity and selectivity, which is critical for drug efficacy and safety. Commonly employed in late-stage functionalization processes to build complex drug molecules with high enantiomeric purity.